Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Paris - Delayed Quote EUR

Eurofins Scientific SE (ERF.PA)

57.70
+1.12
+(1.98%)
At close: 5:35:23 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
6,951,000
6,951,000
6,514,600
6,712,100
6,717,700
Cost of Revenue
2,238,800
2,238,800
2,151,100
2,227,000
2,149,700
Gross Profit
4,712,200
4,712,200
4,363,500
4,485,100
4,568,000
Operating Expense
3,986,000
3,986,000
3,816,700
3,701,900
3,292,700
Operating Income
726,200
726,200
546,800
783,200
1,275,300
Net Non Operating Interest Income Expense
-131,500
-131,500
-117,800
-103,900
-185,500
Pretax Income
554,600
554,600
423,300
780,000
1,056,600
Tax Provision
149,100
149,100
115,500
174,200
273,600
Net Income Common Stockholders
406,400
406,400
310,200
610,200
782,600
Diluted NI Available to Com Stockholders
406,400
406,400
310,200
610,200
782,600
Basic EPS
1.96
2.13
1.61
3.17
4.09
Diluted EPS
1.94
2.09
1.57
3.07
3.90
Basic Average Shares
192,950
190,600
192,900
192,500
191,500
Diluted Average Shares
196,400
194,500
197,900
199,000
200,600
Total Expenses
6,224,800
6,224,800
5,967,800
5,928,900
5,442,400
Net Income from Continuing & Discontinued Operation
406,400
406,400
310,200
610,200
782,600
Normalized Income
437,506.70
437,506.70
322,704.40
507,325.20
795,419.30
Interest Income
19,300
19,300
11,600
2,200
2,000
Interest Expense
150,800
150,800
129,400
105,600
95,000
Net Interest Income
-131,500
-131,500
-117,800
-103,900
-185,500
EBIT
705,400
705,400
552,700
885,600
1,151,600
EBITDA
1,396,800
1,396,800
1,217,000
1,494,500
1,694,200
Reconciled Cost of Revenue
2,238,800
2,238,800
2,151,100
2,227,000
2,149,700
Reconciled Depreciation
596,900
596,900
565,000
504,400
450,700
Net Income from Continuing Operation Net Minority Interest
406,400
406,400
310,200
610,200
782,600
Total Unusual Items Excluding Goodwill
-45,700
-45,700
-17,200
132,400
-17,300
Total Unusual Items
-48,000
-48,000
-17,200
132,400
-17,300
Normalized EBITDA
1,444,800
1,444,800
1,234,200
1,362,100
1,711,500
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-12,293.30
-12,293.30
-4,695.60
29,525.20
-4,480.70
12/31/2021 - 10/27/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BIM.PA bioMérieux S.A.
118.20
-0.34%
 
LO3A.BE Lonza Group Ltd
64.00
-0.78%
 
LONN.SW Lonza Group AG
598.00
-0.30%
 
2359.HK WuXi AppTec Co., Ltd.
64.400
+7.07%
 
BIM.VI bioMérieux S.A.
117.70
-0.93%
 
BMXXY bioMérieux S.A.
9.51
-16.73%
 
ABDXF Abingdon Health Plc
0.0700
0.00%
 
EYWN.DU BioMerieux SA
118.10
-0.42%
 
EYWN.HA BioMerieux SA
117.80
-0.42%
 
LO3.MU Lonza Group Ltd
643.00
+1.26%